Global Radiopharmaceuticals Market Insights, Forecast to 2025
- Report ID : RPT-65555CMR
- Date : September 2020
- Pharmaceutical
- No of Pages : 126
Description
This report studies the global market size of Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiopharmaceuticals in these regions.
This research report categorizes the global Radiopharmaceuticals market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
In 2017, the global Radiopharmaceuticals market size was 4900 million US$ and is forecast to 8410 million US in 2025, growing at a CAGR of 8.0% from 2018. The objectives of this study are to define, segment, and project the size of the Radiopharmaceuticals market based on company, product type, application and key regions.
The various contributors involved in the value chain of Radiopharmaceuticals include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Radiopharmaceuticals include
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market Size Split by Type
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Market Size Split by Application
Oncology
Cardiology
Other
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Radiopharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Radiopharmaceuticals are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Covered Key Topics
Growth Opportunities
Market Growth Drivers
Leading Market Players
Company Market Share
Market Size and Growth Rate
Market Trend and Technological
TOC
1 Study Coverage
1.1 Radiopharmaceuticals Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 Diagnostic Radioisotopes
1.4.3 Therapeutic Radioisotopes
1.5 Market by Application
1.5.1 Global Radiopharmaceuticals Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals Market Size
2.1.1 Global Radiopharmaceuticals Revenue 2016-2025
2.1.2 Global Radiopharmaceuticals Sales 2016-2025
2.2 Radiopharmaceuticals Growth Rate by Regions
2.2.1 Global Radiopharmaceuticals Sales by Regions
2.2.2 Global Radiopharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Radiopharmaceuticals Sales by Manufacturers
3.1.1 Radiopharmaceuticals Sales by Manufacturers
3.1.2 Radiopharmaceuticals Sales Market Share by Manufacturers
3.1.3 Global Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Radiopharmaceuticals Revenue by Manufacturers (2016-2018)
3.2.2 Radiopharmaceuticals Revenue Share by Manufacturers (2016-2018)
3.3 Radiopharmaceuticals Price by Manufacturers
3.4 Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceuticals Product Category
3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Radiopharmaceuticals Sales by Type
4.2 Global Radiopharmaceuticals Revenue by Type
4.3 Radiopharmaceuticals Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Radiopharmaceuticals Breakdown Data by Application
6 North America
6.1 North America Radiopharmaceuticals by Countries
6.1.1 North America Radiopharmaceuticals Sales by Countries
6.1.2 North America Radiopharmaceuticals Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Radiopharmaceuticals by Type
6.3 North America Radiopharmaceuticals by Application
6.4 North America Radiopharmaceuticals by Company
7 Europe
7.1 Europe Radiopharmaceuticals by Countries
7.1.1 Europe Radiopharmaceuticals Sales by Countries
7.1.2 Europe Radiopharmaceuticals Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radiopharmaceuticals by Type
7.3 Europe Radiopharmaceuticals by Application
7.4 Europe Radiopharmaceuticals by Company
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals by Countries
8.1.1 Asia Pacific Radiopharmaceuticals Sales by Countries
8.1.2 Asia Pacific Radiopharmaceuticals Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Radiopharmaceuticals by Type
8.3 Asia Pacific Radiopharmaceuticals by Application
8.4 Asia Pacific Radiopharmaceuticals by Company
9 Central & South America
9.1 Central & South America Radiopharmaceuticals by Countries
9.1.1 Central & South America Radiopharmaceuticals Sales by Countries
9.1.2 Central & South America Radiopharmaceuticals Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Radiopharmaceuticals by Type
9.3 Central & South America Radiopharmaceuticals by Application
9.4 Central & South America Radiopharmaceuticals by Company
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals by Countries
10.1.1 Middle East and Africa Radiopharmaceuticals Sales by Countries
10.1.2 Middle East and Africa Radiopharmaceuticals Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Radiopharmaceuticals by Type
10.3 Middle East and Africa Radiopharmaceuticals by Application
10.4 Middle East and Africa Radiopharmaceuticals by Company
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.1.4 Radiopharmaceuticals Product Description
11.1.5 Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.2.4 Radiopharmaceuticals Product Description
11.2.5 Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.3.4 Radiopharmaceuticals Product Description
11.3.5 Recent Development
11.4 Nordion
11.4.1 Nordion Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.4.4 Radiopharmaceuticals Product Description
11.4.5 Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.5.4 Radiopharmaceuticals Product Description
11.5.5 Recent Development
11.6 Lantheus
11.6.1 Lantheus Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.6.4 Radiopharmaceuticals Product Description
11.6.5 Recent Development
11.7 IBA Group
11.7.1 IBA Group Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.7.4 Radiopharmaceuticals Product Description
11.7.5 Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.8.4 Radiopharmaceuticals Product Description
11.8.5 Recent Development
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.9.4 Radiopharmaceuticals Product Description
11.9.5 Recent Development
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.10.4 Radiopharmaceuticals Product Description
11.10.5 Recent Development
11.11 Eli Lilly
11.12 Advanced Accelerator Applications
11.13 SIEMENS
11.14 Dongcheng
11.15 Navidea
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Radiopharmaceuticals Raw Material
13.1.2 Radiopharmaceuticals Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Tables & Figures
Figure Picture of Radiopharmaceuticals
Figure Global Radiopharmaceuticals Production (K Dose) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Radiopharmaceuticals Production Market Share by Types (Product Category) in 2017
Figure Diagnostic Radioisotopes Product Picture
Table Major Manufacturers of Diagnostic Radioisotopes
Figure Therapeutic Radioisotopes Product Picture
Table Major Manufacturers of Therapeutic Radioisotopes
Table Global Radiopharmaceuticals Market Size Growth Rate by Application 2018-2025 (K Dose)
Figure Oncology
Figure Cardiology
Figure Other
Figure Radiopharmaceuticals Report Years Considered
Figure Global Radiopharmaceuticals Market Size 2016-2025 (Million US$)
Figure Global Radiopharmaceuticals Sales 2016-2025 (K Dose)
Table Global Radiopharmaceuticals Market Size by Regions 2016-2025 (K Dose) & (Million US$)
Table Global Radiopharmaceuticals Sales by Regions 2016-2025 (K Dose)
Table Global Radiopharmaceuticals Sales Market Share by Regions 2016-2025
Figure Global Radiopharmaceuticals Sales Market Share by Regions 2016-2025
Figure 2017 Global Radiopharmaceuticals Sales Market Share by Regions
Table Global Radiopharmaceuticals Revenue by Regions 2016-2025 (Million US$)
Table Global Radiopharmaceuticals Revenue Market Share by Regions 2016-2025
Figure Global Radiopharmaceuticals Revenue Market Share by Regions 2016-2025
Figure 2017 Global Radiopharmaceuticals Revenue Market Share by Regions
Table Global Radiopharmaceuticals Sales by Manufacturers (2016-2018) (K Dose)
Table Global Radiopharmaceuticals Sales Share by Manufacturers (2016-2018)
Figure Global Radiopharmaceuticals Sales Share by Manufacturers in 2017
Table Radiopharmaceuticals Revenue by Manufacturers (2016-2018) (Million US$)
Table Radiopharmaceuticals Revenue Share by Manufacturers (2016-2018)
Figure Radiopharmaceuticals Value Share by Manufacturers in 2017
Table Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Radiopharmaceuticals Price (2016-2018) (USD/Dose)
Table Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Radiopharmaceuticals Product Category
Table Date of International Manufacturers Enter into Radiopharmaceuticals Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Radiopharmaceuticals Sales by Type (2016-2025) (K Dose)
Table Global Radiopharmaceuticals Sales Share by Type (2016-2025)
Figure Global Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure Global Radiopharmaceuticals Sales Market Share by Type in 2017
Table Global Radiopharmaceuticals Revenue by Type (2016-2025) (Million US$)
Table Global Radiopharmaceuticals Revenue Share by Type (2016-2025)
Figure Global Radiopharmaceuticals Revenue Market Share by Type (2016-2025)
Figure Global Radiopharmaceuticals Revenue Market Share by Type in 2017
Table Radiopharmaceuticals Price by Type 2013-2018 (USD/Dose)
Table Global Radiopharmaceuticals Sales by Application (2016-2025) (K Dose)
Table Global Radiopharmaceuticals Sales Share by Application (2016-2025)
Figure Global Sales Radiopharmaceuticals Market Share by Application (2016-2025)
Figure Global Sales Radiopharmaceuticals Market Share by Application (2016-2025)
Figure North America Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Dose)
Figure North America Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table North America Radiopharmaceuticals Sales by Countries (2016-2025) (K Dose)
Table North America Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 North America Radiopharmaceuticals Sales Market Share by Countries
Table North America Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table North America Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Radiopharmaceuticals Revenue Market Share by Countries
Figure United States Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure United States Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Canada Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Mexico Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table North America Radiopharmaceuticals Sales by Type (2016-2025) (K Dose)
Table North America Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 North America Radiopharmaceuticals Market Share by Type
Table North America Radiopharmaceuticals Sales by Application (2016-2025) (K Dose)
Table North America Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 North America Radiopharmaceuticals Market Share by Application
Table North America Radiopharmaceuticals Sales by Company (2016-2018) (K Dose)
Table North America Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure North America Radiopharmaceuticals Sales Market Share by Company in 2017
Figure Europe Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Dose)
Figure Europe Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Radiopharmaceuticals Sales by Countries (2016-2025) (K Dose)
Table Europe Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Radiopharmaceuticals Sales Market Share by Countries
Table Europe Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table Europe Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Radiopharmaceuticals Revenue Market Share by Countries
Figure Germany Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Germany Radiopharmaceuticals Revenue Growth Rate (2016-2025) (K Dose)
Figure France Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure France Radiopharmaceuticals Revenue Growth Rate (2016-2025) (K Dose)
Figure UK Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure UK Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Italy Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Russia Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Radiopharmaceuticals Sales by Type (2016-2025) (K Dose)
Table Europe Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 Europe Radiopharmaceuticals Market Share by Type
Table Europe Radiopharmaceuticals Sales by Application (2016-2025) (K Dose)
Table Europe Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 Europe Radiopharmaceuticals Market Share by Application
Table Europe Radiopharmaceuticals Sales by Company (2016-2018) (K Dose)
Table Europe Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure Europe Radiopharmaceuticals Sales Market Share by Company in 2017
Figure Asia Pacific Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Dose)
Figure Asia Pacific Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Radiopharmaceuticals Sales by Countries (2016-2025) (K Dose)
Table Asia Pacific Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Radiopharmaceuticals Sales Market Share by Countries
Table Asia Pacific Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Radiopharmaceuticals Revenue Market Share by Countries
Figure China Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure China Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Japan Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Korea Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure India Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure India Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Australia Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Indonesia Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Malaysia Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Philippines Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Thailand Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Vietnam Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Singapore Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Radiopharmaceuticals Sales by Type (2016-2025) (K Dose)
Table Asia Pacific Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Radiopharmaceuticals Market Share by Type
Table Asia Pacific Radiopharmaceuticals Sales by Application (2016-2025) (K Dose)
Table Asia Pacific Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Radiopharmaceuticals Market Share by Application
Table Asia Pacific Radiopharmaceuticals Sales by Company (2016-2018) (K Dose)
Table Asia Pacific Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure Asia Pacific Radiopharmaceuticals Sales Market Share by Company in 2017
Figure Central & South America Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Dose)
Figure Central & South America Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Radiopharmaceuticals Sales by Countries (2016-2025) (K Dose)
Table Central & South America Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Radiopharmaceuticals Sales Market Share by Countries
Table Central & South America Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Radiopharmaceuticals Revenue Market Share by Countries
Figure Brazil Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Brazil Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Argentina Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Radiopharmaceuticals Sales by Type (2016-2025) (K Dose)
Table Central & South America Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Radiopharmaceuticals Market Share by Type
Table Central & South America Radiopharmaceuticals Sales by Application (2016-2025) (K Dose)
Table Central & South America Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Radiopharmaceuticals Market Share by Application
Table Central & South America Radiopharmaceuticals Sales by Company (2016-2018) (K Dose)
Table Central & South America Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure Central & South America Radiopharmaceuticals Sales Market Share by Company in 2017
Figure Middle East and Africa Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Dose)
Figure Middle East and Africa Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Radiopharmaceuticals Sales by Countries (2016-2025) (K Dose)
Table Middle East and Africa Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Radiopharmaceuticals Sales Market Share by Countries
Table Middle East and Africa Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Radiopharmaceuticals Revenue Market Share by Countries
Figure GCC Countries Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure GCC Countries Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Turkey Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure Egypt Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Dose)
Figure South Africa Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Radiopharmaceuticals Sales by Type (2016-2025) (K Dose)
Table Middle East and Africa Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Radiopharmaceuticals Market Share by Type
Table Middle East and Africa Radiopharmaceuticals Sales by Application (2016-2025) (K Dose)
Table Middle East and Africa Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Radiopharmaceuticals Market Share by Application
Table Middle East and Africa Radiopharmaceuticals Sales by Company (2016-2018) (K Dose)
Table Middle East and Africa Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Radiopharmaceuticals Sales Market Share by Company in 2017
Table Bracco Imaging Company Details
Table Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Bracco Imaging Recent Development
Table Bayer Company Details
Table Bayer Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Bayer Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Mallinckrodt Recent Development
Table Nordion Company Details
Table Nordion Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Nordion Recent Development
Table Triad Isotopes Company Details
Table Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Triad Isotopes Recent Development
Table Lantheus Company Details
Table Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Lantheus Recent Development
Table IBA Group Company Details
Table IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table IBA Group Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table GE Healthcare Recent Development
Table China Isotope & Radiation Company Details
Table China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table China Isotope & Radiation Recent Development
Table Jubilant Pharma Company Details
Table Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Jubilant Pharma Recent Development
Table Eli Lilly Company Details
Table Advanced Accelerator Applications Company Details
Table SIEMENS Company Details
Table Dongcheng Company Details
Table Navidea Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Radiopharmaceuticals Value Chain
Table Typical Suppliers of Key Radiopharmaceuticals Raw Material
Table Radiopharmaceuticals Customers List
Table Radiopharmaceuticals Sales Channels
Table Radiopharmaceuticals Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies:
Our Clients
